Williams Syndrome Clinical Trial
Official title:
Vitamin D Metabolism and the Williams Syndrome
The Williams syndrome is a disease in which supravalvular aortic stenosis, an elfin facies, mental retardation and other congenital defects are sometimes associated with abnormal vitamin D and calcium metabolism. Whereas some patients have been reported to show increased sensitivity to vitamin D or an exaggerated response of serum 25-hydroxyvitamin D {25(OH)D} to administration of vitamin D and to have hypercalcemia caused by increased circulating 1,25-dihydroxyvitamin D{1,25(OH)2D} in infancy and early childhood, most patients have normal calcium metabolism and normal values for circulating 25(OH)D and 1,25(OH)2D. We propose to carry out further studies of vitamin D metabolism to elucidate the mechanism(s) for abnormal vitamin D metabolism. We will determine the response of serum 1,25(OH)2D to administration of 1,25(OH)2D3. Measurement of the 1,25(OH)2D in the patients compared to normal subjects will be the primary outcome.
n/a
Observational Model: Case Control
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00004351 -
Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
|
N/A | |
Completed |
NCT03758651 -
Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study
|
||
Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
Completed |
NCT02212314 -
Response Inhibition Training for Children With Williams Syndrome
|
N/A | |
Recruiting |
NCT00768820 -
The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
|
Phase 4 | |
Recruiting |
NCT04610424 -
Cooperative Parent Mediated Therapy in Children With Fragile X Syndrome and Williams Syndrome
|
N/A | |
Recruiting |
NCT02706639 -
Williams Syndrome (WS) and Supravalvar Aortic Stenosis (SVAS) DNA and Tissue Bank
|
||
Completed |
NCT02692846 -
WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)
|
||
Recruiting |
NCT06315699 -
Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome
|
Phase 3 | |
Recruiting |
NCT01793168 -
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
|
||
Recruiting |
NCT01132885 -
Defining the Brain Phenotype of Children With Williams Syndrome
|
||
Enrolling by invitation |
NCT05430763 -
Motor Deficits and Signal Conduction in Individuals With Williams Syndrome
|
||
Completed |
NCT01864304 -
Fat Distribution and Glucose Metabolism in Williams Syndrome
|
N/A | |
Recruiting |
NCT02840448 -
Impact of Elastin Mediated Vascular Stiffness on End Organs
|
||
Recruiting |
NCT03827525 -
Cognitive and Behavioral Therapy of Anxiety in Williams Syndrome
|
||
Completed |
NCT04807517 -
Buspirone Treatment of Anxiety in Williams Syndrome
|
Phase 4 | |
Recruiting |
NCT06087757 -
Clemastine Treatment in Individuals With Williams Syndrome
|
Phase 3 |